ROKIT Healthcare Inc. (KOSDAQ:376900)

South Korea flag South Korea · Delayed Price · Currency is KRW
47,050
-4,150 (-8.11%)
At close: Jun 8, 2026
Market Cap784.32B +423.7%
Revenue (ttm)30.61B +126.5%
Net Income-4.32B
EPS-292.09
Shares Out 15.83M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume107,871
Open44,000
Previous Close51,200
Day's Range44,000 - 49,000
52-Week Range13,740 - 153,800
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateApr 10, 2026

About ROKIT Healthcare

ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellul... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376900
Full Company Profile

Financial Performance

In 2025, ROKIT Healthcare's revenue was 26.25 billion, an increase of 100.19% compared to the previous year's 13.11 billion. Losses were -2.85 billion, -62.79% less than in 2024.

Financial Statements